ClinicalTrials.Veeva

Menu

Effect of Kinesiotape on Emesis in Pregnant Women

Cairo University (CU) logo

Cairo University (CU)

Status

Not yet enrolling

Conditions

Emesis Pregnancy

Treatments

Dietary Supplement: Vitamin B6
Drug: Antiemetic Drug
Other: Kinesiotaping
Other: Home care advice

Study type

Interventional

Funder types

Other

Identifiers

NCT06625632
P.T.REC/012/005305

Details and patient eligibility

About

This study will be conducted to investigate the effect of kinesiotaping on emesis in pregnant women.

Full description

Emesis gravidarum (EG) is a common condition among pregnant women, with a prevalence of 12.5% worldwide. It has a significant impact on the body where the mother becomes very weak, the face is pale and the frequency of urination decreases drastically so, the body fluids are reduced, and blood becomes thick (hem concentration). This condition can slow down blood circulation so that oxygen and food supply to the tissues are also reduced which can cause tissue damage and endangers the health of the mother and her fetus. Also, EG known to reduce a woman's quality of life (QOL). It was reported that 80% of women with emesis have reduced QOL.

Women with EG fear from the use of the antiemetic drugs and the possible side effects such as drowsiness, sedation, arrhythmia, poor efficacy of pharmacological approach in the past leads to difficulty in the treatment of nausea and vomiting during pregnancy. Non- pharmacological option has been proposed to be effective in the treatment of EG and hyperemesis gravidarum. Such as hypnosis, acustimulation, tactile massage, psychotherapy, acupuncture and kinesiotape.

Kinesiotape is a drug-free and an elastic therapeutic tape used for treating various musculoskeletal problems such as injury, pain, and dysfunction and a variety of other disorders. The kinesiotaping was found to be effective in stimulation of large and small intestinal peristalsis.

Due to lack of previous studies that examined the effect of kinesiotape on EG. This raises the need of further studies in this issue which will give an insight about the efficacy of kinesiotape as a safe, non-invasive and inexpensive method used to alleviate nausea and vomiting during pregnancy. This will be of valuable benefits in medical service organization and increase body of knowledge of physical therapists in scientific field.

Enrollment

50 estimated patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Fifty pregnant women at 6th to 12th weeks of gestation diagnosed with mild to moderate nausea and vomiting.
  • The diagnosis of EG is confirmed by Rhodes index.
  • Their ages will be ranged from 20 to 35years old.
  • Their body mass index will be less than 30 kg/m2.
  • All of them are primigravida.

Exclusion criteria

  • Digestive system diseases, inflammatory bowel disease, gastric ulcers and/or esophagitis.
  • Twins or more.
  • Obese women with BMI <30 kg/m2.
  • Severe emesis or hyperemesis gravidarum.
  • Risk of threatened or habitual abortion.
  • Multi gravida.
  • Thyroid or liver dysfunction.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

Antiemetic drug + Vitamin B6 + Home care advice + Kinesiotaping
Experimental group
Description:
It will be consisted of 25 pregnant women who will receive kinesiotaping (I band) for 5 days in addition to antiemetic drugs (ondansetron 4 mg, every 12 hours), vitamin B6 (50 mg, once daily), and home care advice.
Treatment:
Other: Home care advice
Other: Kinesiotaping
Drug: Antiemetic Drug
Dietary Supplement: Vitamin B6
Antiemetic drug + Vitamin B6 + Home care advice
Active Comparator group
Description:
It will be consisted of 25 pregnant women who will receive antiemetic drugs (ondansetron 4mg every 12 hours, vitamin B6 (50 mg, once daily), and home care advice only for 5 days.
Treatment:
Other: Home care advice
Drug: Antiemetic Drug
Dietary Supplement: Vitamin B6

Trial contacts and locations

1

Loading...

Central trial contact

Manal Ahmed El-Shafei, PhD; Soad Mansour Shawky El-Kholy, B.Sc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems